FIB trial: Fascia-iliaca block versus 'three-in-one' block for femoral neck fractures

ISRCTN ISRCTN16152419
DOI https://doi.org/10.1186/ISRCTN16152419
Secondary identifying numbers 7820
Submission date
23/04/2010
Registration date
23/04/2010
Last edited
24/05/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jonathan Benger
Scientific

Bristol Royal Infirmary
Department of Emergency Medicine
Academic Department of Emergency Care
Bristol
BS2 8HW
United Kingdom

Study information

Study designRandomised interventional process of care trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised trial of the fascia-iliaca block versus the 'three-in-one' block for femoral neck fractures in the emergency department
Study acronymFIB trial
Study objectivesThe FIB trial is a two group randomised equivalence trial investigating the effects of the fascia-iliaca block versus the "three-in-one" block on pain scores and analgesia requirement in the subsequent 24 hour period, in patients with radiologically confirmed fractured neck of femur presenting to the emergency department. The primary null hypothesis is that the fascia-iliaca block will be as effective as the "three-in-one" block in reducing pain and anlagesia requirement.
Ethics approval(s)Frenchay Ethics Committee approved on the 14th February 2008 (ref: 07/H0107/65)
Health condition(s) or problem(s) studiedTopic: Injuries and Accidents; Subtopic: Injuries and Accidents (all Subtopics); Disease: Injuries & Accidents
InterventionIntervention arm:
Fascia-iliaca block (FIB): At the point 1 cm beneath the junction of the outer and middle thirds of a line drawn between the superior anterior iliac crest and the pubic tubercle a 18G tuohy needle is inserted at 90 degrees until two distinct pops are felt as it penetrates the fascia lata and then fascia iliaca. The needle is aspirated to exclude intra-vascular placement and the sub-fascial compartment is then filled with 2 mg/kg (max 150 mg) of bupivicaine solution diluted to a volume of 30 ml if required.

Control arm:
3 in 1 Femoral Nerve Block: At the femoral crease immediately lateral to the femoral arterial pulse a stimuplex needle will be guided to within the femoral sheath using a nerve stimulator. When the needle is appropriately placed linear patellar movement will be seen at 30 mV but not less than 30 mV. At this time the needle will be aspirated to exclude intra-vascular placement and femoral sheath is injected with 2 mg/kg (max 150 mg) of bupivicaine solution diluted to a volume of 30 ml if required whilst occluding the femoral sheath to prevent distal LA spread.

Follow up period: 24 hours
Intervention typeProcedure/Surgery
Primary outcome measurePain as measured by the Visual Anologue Scale (VAS) score (0 = no pain, 10 = unbearable pain), at 0 minutes, 30 minutes and 60 minutes
Secondary outcome measures1. Analgesia consumption: sum quantity of analgesia given within 24 hours of the block, measured at 24 hours post-nerve block
2. Hospital length of stay
Overall study start date01/12/2008
Completion date01/12/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 190
Key inclusion criteria1. Patients with radiologically confirmed unilateral fractured neck of femur presenting to emergency department
2. Capacity to consent to participate in study
3. Aged greater than or equal to 18 years, either sex
Key exclusion criteria1. Patients unable to consent due to delirium, dementia or incapacity
2. Patients with other distracting painful pathology; patients with reduced level of consciousness
3. Patients who present greater than 24 hours post-injury
4. Patients for whom use of local anaesthesia agents is contraindicated
5. Patients who decline to take part in the study
6. Patients who are unable to speak or understand English
Date of first enrolment01/12/2008
Date of final enrolment01/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Bristol Royal Infirmary
Bristol
BS2 8HW
United Kingdom

Sponsor information

Bristol Royal Infirmary (UK)
Hospital/treatment centre

Gastroenterology Research Group, Research Floor Level 7
Bristol Royal Infirmary
Marlborough Street
Bristol
BS2 8HW
England
United Kingdom

Website http://www.uhbristol.nhs.uk/your-hospitals/bristol-royal-infirmary.html
ROR logo "ROR" https://ror.org/031p4kj21

Funders

Funder type

University/education

The College of Emergency Medicine (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2015 Yes No

Editorial Notes

24/05/2016: Publication reference added.